High affinity ligands from in vitro selection: complex targets.
about
A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichmentNeutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinaseGenerating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEXOligonucleotide Functionalised Microbeads: Indispensable Tools for High-Throughput Aptamer SelectionIn Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid LibrariesProgress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsNucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical SensingDevelopment of an aptamer-based concentration method for the detection of Trypanosoma cruzi in bloodDevelopment of Cell-SELEX Technology and Its Application in Cancer Diagnosis and TherapyChallenges and opportunities for small molecule aptamer developmentDevelopment of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodRNA plasticity and selectivity applicable to therapeutics and novel biosensor developmentDifferential SELEX in human glioma cell linesDrug delivery systems in urology--getting "smarter".Thrombin-Binding Aptamer Quadruplex Formation: AFM and Voltammetric Characterization.RNA and DNA aptamers as potential tools to prevent cell adhesion in disease.Nucleic acid aptamers in cancer medicine.A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin.SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription.Deconvolution of a complex target using DNA aptamers.Cell-specific aptamers for targeted therapies.Boron-containing aptamers to ATP.Development of DNA aptamers using Cell-SELEX.Aptamers and the next generation of diagnostic reagents.Label-free fluorescent aptamer sensor based on regulation of malachite green fluorescence.DNA aptamers as molecular probes for colorectal cancer study.Strategies for the discovery of therapeutic aptamers.Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapyAptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cellsPorous silicon antibody microarrays for quantitative analysis: measurement of free and total PSA in clinical plasma samplesEvolutionary dynamics and population control during in vitro selection and amplification with multiple targets.Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selectionNew Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.Targeting stem cells-clinical implications for cancer therapy.Cell-SELEX TechnologyAptamers: versatile probes for flow cytometry.Aptamers evolved from live cells as effective molecular probes for cancer study.In vivo imaging with oligonucleotides for diagnosis and drug development.
P2860
Q24618342-0B6EE5F1-88AE-47FB-BE3B-02A2EBD34D99Q24803451-8071FE50-00CD-4C7A-B85F-CB06C20DEA57Q26744825-0B1CA3AE-A43E-44B7-807C-FCEF39548004Q26775102-B985659D-64F7-4E17-B81B-BE4FD6C5C68BQ26782129-3348A9F0-AD46-449E-9F59-9AF5902725F5Q26782485-A95F5BB9-DE29-42EF-8BA6-9AB8A08506D6Q26825644-D27758C9-FE64-4264-8551-C51CFD1C2BE9Q27322870-FFAF8F85-B283-4F51-8C4E-DED23AD2525FQ28080168-B0315CF5-8ED5-405F-A0EC-6C5D112CD39AQ28484847-0C25E1FA-254E-41B8-94B6-F11E0168D5C2Q28485460-EA23339F-0EF6-47D7-A486-E4C1A3CC6429Q28727743-E774C920-0558-48B9-9012-6573A00E9716Q28750173-76C89C0E-98F4-443E-A043-5B11F115270DQ30478170-E7738C8F-8915-471C-B5CF-014BD5419738Q30479872-D42CF592-220F-4FCB-AA43-F547DF1938D7Q30659888-6C5DCC41-8815-41F2-B53E-BB2282C7AA1AQ30854890-4099E532-469D-4B3D-90DA-60C0CBDC7FECQ31111010-09FB5132-8250-409E-BF77-38474F7AB365Q33206025-CE71DEB4-0484-4C22-B46E-02A3B1FD982BQ33221136-837BE5F9-C9DA-440A-9042-59908F70F0D7Q33432043-512E660A-172B-4C8E-B5E0-B5237403F8BAQ33587011-08AA4E48-4A7C-47FA-8E57-3578BF9E6035Q33600982-75295D77-19AE-4622-B8B2-95C1488CDD60Q33615065-C129F964-8535-47F9-8765-6670102B15DAQ33653160-6CC2244F-9C79-4DE9-B360-453D226AED95Q33775559-4AB1D98E-F7DD-4562-BE98-A2AFC615DE5BQ33831862-6F0DB754-F2D8-41BB-BB51-2AFBE54049BBQ33901924-180DF318-582E-4FF8-855C-BE8A1C41008DQ34077138-79949430-21BD-41E5-AE4D-C8640FAF0F78Q34152258-F5646C66-4215-401C-9AA5-760C3111F83EQ34247575-95E51C23-09FA-4354-BEF7-71B09B3530F8Q34361084-E09D986A-6ED4-4ADB-9DAE-B11E8D1F0A3AQ34364852-7EB69239-E0C5-4C48-BDD7-BA878AA8C035Q34409758-698A52F9-C47E-4BDC-A08D-94E65A69D01BQ34459376-7DCFC149-6BA4-4CBA-A600-D3E6CB764457Q34555251-FEA6BCAF-9D58-4EAF-99D7-741516D5583FQ34628815-859BED9A-E122-4088-A3FC-958298A1BB99Q34803826-CAE4625E-8CD3-449D-8B10-D6E9AED1B094Q35033059-E1012B6E-CCB1-4613-911D-331BCDCBBC17Q35127223-D3C39B78-7EC7-45AB-8746-D4E5E716E2D9
P2860
High affinity ligands from in vitro selection: complex targets.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
High affinity ligands from in vitro selection: complex targets.
@ast
High affinity ligands from in vitro selection: complex targets.
@en
type
label
High affinity ligands from in vitro selection: complex targets.
@ast
High affinity ligands from in vitro selection: complex targets.
@en
prefLabel
High affinity ligands from in vitro selection: complex targets.
@ast
High affinity ligands from in vitro selection: complex targets.
@en
P2093
P2860
P356
P1476
High affinity ligands from in vitro selection: complex targets
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.6.2902
P407
P577
1998-03-01T00:00:00Z